Acuta Capital Partners as of June 30, 2023
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 35 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 18.4 | $27M | 298k | 91.10 | |
| Aadi Bioscience (AADI) | 8.6 | $13M | 1.8M | 6.84 | |
| Terns Pharmaceuticals (TERN) | 5.8 | $8.5M | 970k | 8.75 | |
| Kura Oncology (KURA) | 5.1 | $7.5M | 709k | 10.58 | |
| Syndax Pharmaceuticals (SNDX) | 4.3 | $6.3M | 300k | 20.93 | |
| Disc Medicine (IRON) | 4.2 | $6.2M | 140k | 44.40 | |
| Vaxcyte (PCVX) | 4.1 | $6.1M | 122k | 49.94 | |
| Rocket Pharmaceuticals (RCKT) | 4.1 | $6.1M | 306k | 19.87 | |
| Miragen Therapeutics (VRDN) | 3.6 | $5.3M | 225k | 23.79 | |
| Iveric Bio | 3.5 | $5.2M | 132k | 39.34 | |
| Argenx Se Sponsored Adr (ARGX) | 3.3 | $4.9M | 13k | 389.73 | |
| Praxis Precision Medicines I | 3.3 | $4.9M | 4.3M | 1.15 | |
| Ventyx Biosciences (VTYX) | 3.3 | $4.8M | 147k | 32.80 | |
| Cymabay Therapeutics | 3.2 | $4.7M | 430k | 10.95 | |
| Celldex Therapeutics Com New (CLDX) | 2.8 | $4.2M | 122k | 33.93 | |
| Clene Common Stock | 2.5 | $3.7M | 4.2M | 0.88 | |
| Ikena Oncology (IKNA) | 2.5 | $3.7M | 558k | 6.56 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 2.3 | $3.3M | 382k | 8.70 | |
| Gh Research Ordinary Shares (GHRS) | 2.0 | $2.9M | 245k | 11.87 | |
| Immunovant (IMVT) | 1.8 | $2.7M | 142k | 18.97 | |
| Verastem Com New (VSTM) | 1.5 | $2.2M | 300k | 7.44 | |
| Roivant Sciences Shares (ROIV) | 1.5 | $2.2M | 220k | 10.08 | |
| Enliven Therapeutics (ELVN) | 1.4 | $2.1M | 105k | 20.41 | |
| Alkermes SHS (ALKS) | 0.9 | $1.4M | 45k | 31.30 | |
| Aclaris Therapeutics (ACRS) | 0.9 | $1.3M | 122k | 10.37 | |
| Hillevax (HLVX) | 0.7 | $1.1M | 63k | 17.19 | |
| Morphic Hldg (MORF) | 0.7 | $1.0M | 18k | 57.33 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.7 | $981k | 28k | 35.66 | |
| Olema Pharmaceuticals (OLMA) | 0.6 | $956k | 106k | 9.03 | |
| Biomea Fusion (BMEA) | 0.6 | $878k | 40k | 21.95 | |
| Dyne Therapeutics (DYN) | 0.6 | $821k | 73k | 11.25 | |
| Rezolute Com New (RZLT) | 0.5 | $739k | 373k | 1.98 | |
| Savara (SVRA) | 0.4 | $633k | 198k | 3.19 | |
| Kronos Bio (KRON) | 0.4 | $542k | 315k | 1.72 | |
| Nuvation Bio *w Exp 07/07/2027 (NUVB.WS) | 0.0 | $15k | 91k | 0.17 |
